ClinVar Miner

Submissions for variant NM_000046.5(ARSB):c.1325C>T (p.Thr442Met)

dbSNP: rs1057520739
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 6
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000435336 SCV000517249 pathogenic not provided 2015-05-27 criteria provided, single submitter clinical testing The T442M variant in the ARSB gene has been reported previously in the compound heterozygous statein an individual with mucopolysaccharidosis type VI (MPS VI) (Karageorgos et al., 2007). The T442Msubstitution was not observed in approximately 6500 individuals of European and African American ancestryin the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations.The T442M variant is a non-conservative amino acid substitution, which is likely to impact secondaryprotein structure as these residues differ in polarity, charge, size and/or other properties. This substitutionoccurs at a position that is conserved across species. Missense variants in the same (T442R) and nearby(K439E, P445L, and G446R) residues have been reported in the Human Gene Mutation Database inassociation with MPS VI (Stenson et al., 2014), supporting the functional importance of this region of theprotein. We interpret T442M as a pathogenic variant.
Labcorp Genetics (formerly Invitae), Labcorp RCV000632186 SCV000753291 pathogenic Mucopolysaccharidosis type 6 2023-04-24 criteria provided, single submitter clinical testing For these reasons, this variant has been classified as Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ARSB protein function. ClinVar contains an entry for this variant (Variation ID: 379809). This missense change has been observed in individual(s) with clinical features of mucopolysaccharidosis type IV (PMID: 17458871, 25190157; Invitae). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces threonine, which is neutral and polar, with methionine, which is neutral and non-polar, at codon 442 of the ARSB protein (p.Thr442Met).
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000632186 SCV003928877 likely pathogenic Mucopolysaccharidosis type 6 2023-04-24 criteria provided, single submitter clinical testing Variant summary: ARSB c.1325C>T (p.Thr442Met) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 251396 control chromosomes (gnomAD). c.1325C>T has been reported in the literature in the compound heterozygous state in individuals affected with Mucopolysaccharidosis Type VI (Maroteaux-Lamy Syndrome), including at least one case where it was found in trans with a pathogenic variant (e.g. Karageorgos_2007, Zheng_2014, Tomanin_2018, He_2021). These data indicate that the variant is likely associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 17458871, 25190157, 30118150, 33985463). Four submitters have provided clinical-significance assessments for this variant to ClinVar after 2014 and classified the variant as either pathogenic (n=2) or VUS (n=2). Based on the evidence outlined above, the variant was classified as likely pathogenic.
Baylor Genetics RCV000632186 SCV004209180 pathogenic Mucopolysaccharidosis type 6 2023-08-24 criteria provided, single submitter clinical testing
Eurofins Ntd Llc (ga) RCV000435336 SCV000706443 uncertain significance not provided 2017-02-21 flagged submission clinical testing
Laboratory of Diagnosis and Therapy of Lysosomal Disorders, University of Padova RCV000632186 SCV000802983 uncertain significance Mucopolysaccharidosis type 6 2018-01-01 flagged submission curation Absent from GnomAD (PM2)

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.